RIPOR1
gene geneOn this page
Also known as FLJ13725
Summary
RIPOR1 (RHO family interacting cell polarization regulator 1, HGNC:25836) is a protein-coding gene on chromosome 16q22.1, encoding Rho family-interacting cell polarization regulator 1 (Q6ZS17). Downstream effector protein for Rho-type small GTPases that plays a role in cell polarity and directional migration.
Enables 14-3-3 protein binding activity. Involved in several processes, including establishment of Golgi localization; negative regulation of Rho guanyl-nucleotide exchange factor activity; and negative regulation of Rho protein signal transduction. Located in several cellular components, including Golgi apparatus; cell leading edge; and cytosol.
Source: NCBI Gene 79567 — automated summary from GO annotations (Alliance of Genome Resources).
At a glance
- GWAS associations: 4
- Clinical variants (ClinVar): 201 total
- GTEx eGene: eQTL in 10 tissues, sQTL in 6 (q < 0.05)
- Constraint (gnomAD): pLI 0.00 (LoF-tolerant), LOEUF 0.61 (unconstrained)
- MANE Select transcript:
NM_024519 - Notable: 201 clinical variants but no curated precision-oncology (CIViC) evidence yet
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:25836 |
| Approved symbol | RIPOR1 |
| Name | RHO family interacting cell polarization regulator 1 |
| Location | 16q22.1 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | FLJ13725 |
| Ensembl gene | ENSG00000039523 |
| Ensembl biotype | protein_coding |
| OMIM | 619842 |
| Entrez | 79567 |
Gene structure
Transcript identifiers
Ensembl transcripts: 41 — 32 protein_coding, 7 retained_intron, 1 protein_coding_CDS_not_defined, 1 nonsense_mediated_decay
MANE Select: ENST00000042381
Transcript support level (Ensembl TSL; 1 = fully mRNA-supported): TSL 2: 8, TSL 3: 3, TSL 4: 5, TSL 5: 7
ENST00000042381, ENST00000379312, ENST00000422602, ENST00000428437, ENST00000540839, ENST00000561534, ENST00000562116, ENST00000562755, ENST00000564616, ENST00000565176, ENST00000565190, ENST00000565679, ENST00000566522, ENST00000566559, ENST00000566730, ENST00000566815, ENST00000566907, ENST00000566920, ENST00000568959, ENST00000569179, ENST00000569253, ENST00000569474, ENST00000569733, ENST00000860989, ENST00000860990, ENST00000860991, ENST00000860992, ENST00000860993, ENST00000860994, ENST00000860995, ENST00000860996, ENST00000860997, ENST00000860998, ENST00000860999, ENST00000861000, ENST00000861001, ENST00000861002, ENST00000861003, ENST00000965781, ENST00000965782, ENST00001134117
RefSeq mRNA: 5 — MANE Select: NM_024519
NM_001193522, NM_001193523, NM_001193524, NM_001410885, NM_024519
CCDS: CCDS10840, CCDS54026, CCDS54027, CCDS54028, CCDS92176
Canonical transcript exons
ENST00000042381 — 22 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001380181 | 67528829 | 67528914 |
| ENSE00003505157 | 67546366 | 67546786 |
| ENSE00003539957 | 67538424 | 67538550 |
| ENSE00003801384 | 67540300 | 67540363 |
| ENSE00003801433 | 67544956 | 67545117 |
| ENSE00003801861 | 67539846 | 67539899 |
| ENSE00003803162 | 67545664 | 67545860 |
| ENSE00003803502 | 67540579 | 67540704 |
| ENSE00003803768 | 67543348 | 67543469 |
| ENSE00003804977 | 67539728 | 67539751 |
| ENSE00003805247 | 67540053 | 67540205 |
| ENSE00003805827 | 67545376 | 67545534 |
| ENSE00003805966 | 67544299 | 67544431 |
| ENSE00003806300 | 67540458 | 67540501 |
| ENSE00003806516 | 67546141 | 67546231 |
| ENSE00003806764 | 67538990 | 67539068 |
| ENSE00003806783 | 67541430 | 67541578 |
| ENSE00003806883 | 67541653 | 67541782 |
| ENSE00003807048 | 67545949 | 67546032 |
| ENSE00003807054 | 67538672 | 67538824 |
| ENSE00003809764 | 67541867 | 67543264 |
| ENSE00003810335 | 67544695 | 67544830 |
Expression profiles
Bgee: expression breadth ubiquitous, 274 present calls, max score 97.83.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 30.5908 / max 908.5516, expressed in 1805 samples.
Highest expression (Bgee): apex of heart, lung, upper lobe of left lung, renal glomerulus, spleen.
Genetic regulation across tissues (GTEx eQTL / sQTL)
RIPOR1 is an eGene in GTEx v10 — its expression is genetically regulated (eQTL) in 10 tissues and its splicing (sQTL) in 6 (q < 0.05). Strongest associations first; slope = normalized effect of the lead variant’s alternative allele.
16 significant tissue × QTL associations:
| Tissue | QTL | q-value | Slope | Lead variant |
|---|---|---|---|---|
| Brain Cerebellum | eqtl | 1.1e-06 | +0.64 | 16:67534414:G:A |
| Whole Blood | eqtl | 6.8e-06 | -0.13 | 16:67547980:A:G |
| Thyroid | eqtl | 6.9e-06 | -0.28 | 16:67763231:T:C |
| Brain Cerebellar Hemisphere | eqtl | 1.3e-03 | +0.19 | 16:68217881:C:G |
| Cells Cultured fibroblasts | eqtl | 8.8e-03 | +0.32 | 16:68194852:ATATAT:A |
| Colon Sigmoid | eqtl | 1.3e-02 | +0.53 | 16:67408313:G:A |
| Muscle Skeletal | eqtl | 1.6e-02 | +0.09 | 16:68343030:C:A |
| Prostate | eqtl | 1.7e-02 | -0.61 | 16:68368843:C:T |
| Artery Tibial | sqtl | 1.9e-02 | -0.61 | 16:67532667:G:C |
| Skin Sun Exposed Lower leg | eqtl | 2.0e-02 | +0.19 | 16:66697720:C:CT |
| Esophagus Muscularis | sqtl | 2.4e-02 | -0.67 | 16:67544354:C:T |
| Adipose Subcutaneous | eqtl | 2.7e-02 | -0.15 | 16:66597874:C:T |
| Brain Cortex | sqtl | 2.8e-02 | -2.46 | 16:68463290:G:A |
| Minor Salivary Gland | sqtl | 4.0e-02 | +1.37 | 16:67156074:C:G |
| Stomach | sqtl | 4.1e-02 | -1.27 | 16:67140970:G:A |
| Testis | sqtl | 4.6e-02 | -1.27 | 16:66659353:C:T |
FANTOM5 promoters
showing 10 of 11 alternative TSS:
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 154641 | 19.8221 | 1778 |
| 154645 | 6.0305 | 1350 |
| 154654 | 2.1436 | 916 |
| 154655 | 1.1631 | 463 |
| 154656 | 0.9720 | 359 |
| 154657 | 0.3136 | 109 |
| 154643 | 0.0534 | 9 |
| 154639 | 0.0371 | 9 |
| 154642 | 0.0308 | 12 |
| 154640 | 0.0167 | 6 |
Top tissues by expression
showing 100 of 288 tissues by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| apex of heart | UBERON:0002098 | 97.83 | gold quality |
| right lung | UBERON:0002167 | 97.50 | gold quality |
| upper lobe of left lung | UBERON:0008952 | 96.63 | gold quality |
| renal glomerulus | UBERON:0000074 | 96.53 | gold quality |
| spleen | UBERON:0002106 | 96.47 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 96.46 | gold quality |
| metanephric glomerulus | UBERON:0004736 | 96.28 | gold quality |
| right coronary artery | UBERON:0001625 | 96.22 | gold quality |
| right frontal lobe | UBERON:0002810 | 96.19 | gold quality |
| upper lobe of lung | UBERON:0008948 | 96.17 | gold quality |
| metanephros cortex | UBERON:0010533 | 96.07 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 96.03 | gold quality |
| cerebellar cortex | UBERON:0002129 | 95.98 | gold quality |
| ascending aorta | UBERON:0001496 | 95.78 | gold quality |
| cortical plate | UBERON:0005343 | 95.74 | gold quality |
| thoracic aorta | UBERON:0001515 | 95.73 | gold quality |
| body of uterus | UBERON:0009853 | 95.73 | gold quality |
| left uterine tube | UBERON:0001303 | 95.68 | gold quality |
| omental fat pad | UBERON:0010414 | 95.51 | gold quality |
| sural nerve | UBERON:0015488 | 95.49 | gold quality |
| peritoneum | UBERON:0002358 | 95.47 | gold quality |
| lower esophagus muscularis layer | UBERON:0035833 | 95.43 | gold quality |
| lower esophagus | UBERON:0013473 | 95.41 | gold quality |
| descending thoracic aorta | UBERON:0002345 | 95.38 | gold quality |
| aorta | UBERON:0000947 | 95.31 | gold quality |
| left coronary artery | UBERON:0001626 | 95.28 | gold quality |
| cortex of kidney | UBERON:0001225 | 95.25 | gold quality |
| esophagogastric junction muscularis propria | UBERON:0035841 | 95.22 | gold quality |
| endocervix | UBERON:0000458 | 95.19 | gold quality |
| mucosa of stomach | UBERON:0001199 | 95.17 | gold quality |
| popliteal artery | UBERON:0002250 | 95.08 | gold quality |
| tibial artery | UBERON:0007610 | 95.08 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 95.08 | gold quality |
| cingulate cortex | UBERON:0003027 | 95.06 | gold quality |
| cerebellum | UBERON:0002037 | 95.03 | gold quality |
| adipose tissue of abdominal region | UBERON:0007808 | 95.03 | gold quality |
| coronary artery | UBERON:0001621 | 94.98 | gold quality |
| heart left ventricle | UBERON:0002084 | 94.97 | gold quality |
| right atrium auricular region | UBERON:0006631 | 94.94 | gold quality |
| cardiac ventricle | UBERON:0002082 | 94.82 | gold quality |
| right lobe of thyroid gland | UBERON:0001119 | 94.81 | gold quality |
| tibial nerve | UBERON:0001323 | 94.63 | gold quality |
| left lobe of thyroid gland | UBERON:0001120 | 94.58 | gold quality |
| stromal cell of endometrium | CL:0002255 | 94.55 | gold quality |
| nucleus accumbens | UBERON:0001882 | 94.42 | gold quality |
| caudate nucleus | UBERON:0001873 | 94.35 | gold quality |
| ectocervix | UBERON:0012249 | 94.22 | gold quality |
| right ovary | UBERON:0002118 | 94.16 | gold quality |
| adult mammalian kidney | UBERON:0000082 | 94.10 | gold quality |
| putamen | UBERON:0001874 | 94.06 | gold quality |
| lower esophagus mucosa | UBERON:0035834 | 94.03 | gold quality |
| thyroid gland | UBERON:0002046 | 93.92 | gold quality |
| muscle layer of sigmoid colon | UBERON:0035805 | 93.92 | gold quality |
| subcutaneous adipose tissue | UBERON:0002190 | 93.91 | gold quality |
| prefrontal cortex | UBERON:0000451 | 93.90 | gold quality |
| neocortex | UBERON:0001950 | 93.83 | gold quality |
| granulocyte | CL:0000094 | 93.79 | gold quality |
| heart | UBERON:0000948 | 93.77 | gold quality |
| frontal cortex | UBERON:0001870 | 93.75 | gold quality |
| monocyte | CL:0000576 | 93.56 | gold quality |
| cardiac atrium | UBERON:0002081 | 93.55 | gold quality |
| amygdala | UBERON:0001876 | 93.52 | gold quality |
| mononuclear cell | CL:0000842 | 93.47 | gold quality |
| left ovary | UBERON:0002119 | 93.43 | gold quality |
| adenohypophysis | UBERON:0002196 | 93.38 | gold quality |
| gall bladder | UBERON:0002110 | 93.36 | gold quality |
| leukocyte | CL:0000738 | 93.26 | gold quality |
| dorsolateral prefrontal cortex | UBERON:0009834 | 93.26 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 92.98 | gold quality |
| telencephalon | UBERON:0001893 | 92.97 | gold quality |
| cerebral cortex | UBERON:0000956 | 92.92 | gold quality |
| forebrain | UBERON:0001890 | 92.82 | gold quality |
| brain | UBERON:0000955 | 92.69 | gold quality |
| left adrenal gland cortex | UBERON:0035825 | 92.66 | gold quality |
| pituitary gland | UBERON:0000007 | 92.64 | gold quality |
| colonic epithelium | UBERON:0000397 | 92.60 | gold quality |
| left adrenal gland | UBERON:0001234 | 92.56 | gold quality |
| cerebellar vermis | UBERON:0004720 | 92.52 | silver quality |
| body of pancreas | UBERON:0001150 | 92.48 | gold quality |
| right adrenal gland | UBERON:0001233 | 92.34 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 92.34 | gold quality |
| myometrium | UBERON:0001296 | 92.31 | gold quality |
| temporal lobe | UBERON:0001871 | 92.26 | gold quality |
| hypothalamus | UBERON:0001898 | 92.22 | gold quality |
| adipose tissue | UBERON:0001013 | 92.19 | gold quality |
| adrenal cortex | UBERON:0001235 | 92.15 | gold quality |
| small intestine Peyer’s patch | UBERON:0003454 | 92.06 | gold quality |
| connective tissue | UBERON:0002384 | 92.00 | gold quality |
| Ammon’s horn | UBERON:0001954 | 91.97 | gold quality |
| fundus of stomach | UBERON:0001160 | 91.95 | gold quality |
| body of stomach | UBERON:0001161 | 91.84 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 91.82 | gold quality |
| lung | UBERON:0002048 | 91.79 | gold quality |
| esophagus | UBERON:0001043 | 91.78 | gold quality |
| bone marrow cell | CL:0002092 | 91.53 | gold quality |
| gastrocnemius | UBERON:0001388 | 91.51 | gold quality |
| ganglionic eminence | UBERON:0004023 | 91.46 | gold quality |
| smooth muscle tissue | UBERON:0001135 | 91.43 | gold quality |
| muscle of leg | UBERON:0001383 | 91.30 | gold quality |
| minor salivary gland | UBERON:0001830 | 91.24 | gold quality |
Single-cell (SCXA)
Detected in 4 experiment(s), a significant marker in 3.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-CURD-119 | yes | 28.50 |
| E-ANND-3 | yes | 12.95 |
| E-MTAB-9543 | yes | 7.72 |
| E-CURD-112 | no | 2.72 |
HPA expression
RNA tissue specificity: Low tissue specificity
showing 60 of 76 HPA tissues / cells by nTPM:
| Tissue / cell | Axis | nTPM | Protein (IHC) |
|---|---|---|---|
| Hippocampus | tissue | 109.2 | not detected |
| Postcentral gyrus | tissue | 99.9 | |
| Nucleus accumbens | tissue | 94.5 | |
| Locus coeruleus | tissue | 88.1 | |
| Choroid plexus | tissue | 64.5 | |
| Retina | tissue | 40.7 | |
| Spleen | tissue | 40.6 | not detected |
| Heart muscle | tissue | 37.1 | not detected |
| Frontal cortex | tissue | 33.6 | |
| Vagina | tissue | 28.3 | not detected |
| Placenta | tissue | 28.0 | not detected |
| Cerebellum | tissue | 28.0 | low |
| Caudate putamen | tissue | 28.0 | |
| Prefrontal cortex | tissue | 27.9 | |
| Cerebral cortex | tissue | 27.9 | not detected |
| Lung | tissue | 27.9 | low |
| Skeletal muscle | tissue | 27.7 | not detected |
| Adipose tissue | tissue | 27.0 | not detected |
| Insular cortex | tissue | 26.0 | |
| Motor cortex | tissue | 25.8 | |
| Bone marrow | tissue | 25.7 | not detected |
| Occipital cortex | tissue | 25.7 | |
| Somatosensory cortex | tissue | 25.2 | |
| Retrosplenial cortex | tissue | 25.0 | |
| Pituitary gland | tissue | 24.8 | |
| Retrosplenial and cingulate cortex | tissue | 24.7 | |
| Hippocampal formation | tissue | 24.5 | |
| Entorhinal cortex | tissue | 24.4 | |
| Basal ganglia | tissue | 24.1 | not detected |
| Temporal cortex | tissue | 23.8 | |
| Smooth muscle | tissue | 23.5 | not detected |
| Putamen | tissue | 23.5 | |
| Ventral forebrain | tissue | 23.5 | |
| Amygdala | tissue | 22.9 | |
| Pancreas | tissue | 22.6 | low |
| Olfactory bulb | tissue | 22.4 | |
| Superior colliculi | tissue | 22.1 | |
| Appendix | tissue | 22.1 | medium |
| Substantia nigra | tissue | 21.5 | |
| Kidney | tissue | 21.2 | low |
| Corpus callosum | tissue | 21.2 | |
| Hypothalamus | tissue | 21.1 | |
| Midbrain | tissue | 21.0 | |
| Tongue | tissue | 20.8 | |
| Thalamus | tissue | 20.8 | |
| Septum | tissue | 20.8 | |
| Gallbladder | tissue | 20.1 | low |
| Pons | tissue | 19.8 | |
| Endometrium 1 | tissue | 19.7 | not detected |
| Lymph node | tissue | 19.5 | not detected |
| Medulla oblongata | tissue | 19.5 | |
| Spinal cord | tissue | 19.4 | |
| Parathyroid gland | tissue | 19.3 | not detected |
| Seminal vesicle | tissue | 19.0 | not detected |
| Ovary | tissue | 18.9 | not detected |
| Urinary bladder | tissue | 18.0 | medium |
| Cervix | tissue | 17.0 | not detected |
| Periaqueductal gray | tissue | 16.8 | |
| Tonsil | tissue | 16.4 | not detected |
| Thyroid gland | tissue | 15.9 | not detected |
Brain sub-regions (HPA Brain Atlas): detected in 190; highest nTPM — Precentral gyrus (125.3), Hippocampus, CA3 (119.8), Dentate gyrus (115.3), Temporo-occipital transitional zone (112.4), Entorhinal gyrus (111.4).
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
Targeting RIPOR1 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific).
showing 30 of 38 miRNAs:
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-3163 | 100.00 | 77.23 | 8605 |
| HSA-MIR-656-3P | 100.00 | 72.15 | 2788 |
| HSA-MIR-5692A | 100.00 | 74.40 | 6850 |
| HSA-MIR-1277-5P | 100.00 | 73.95 | 5056 |
| HSA-MIR-3686 | 99.90 | 70.53 | 2432 |
| HSA-MIR-345-3P | 99.89 | 70.23 | 1421 |
| HSA-MIR-3140-3P | 99.88 | 68.47 | 2069 |
| HSA-MIR-3151-5P | 99.86 | 63.83 | 1069 |
| HSA-MIR-4447 | 99.85 | 67.81 | 2900 |
| HSA-MIR-4728-5P | 99.85 | 69.39 | 4718 |
| HSA-MIR-6785-5P | 99.82 | 68.68 | 4428 |
| HSA-MIR-4760-5P | 99.80 | 69.88 | 1619 |
| HSA-MIR-6885-3P | 99.75 | 70.36 | 3187 |
| HSA-MIR-6752-3P | 99.72 | 66.71 | 1587 |
| HSA-MIR-1825 | 99.72 | 68.11 | 1089 |
| HSA-MIR-149-3P | 99.72 | 68.22 | 3963 |
| HSA-MIR-6883-5P | 99.69 | 68.05 | 3785 |
| HSA-MIR-8061 | 99.63 | 69.44 | 1411 |
| HSA-MIR-4663 | 99.62 | 65.33 | 957 |
| HSA-MIR-4472 | 99.56 | 66.08 | 1478 |
| HSA-MIR-4688 | 99.48 | 64.68 | 828 |
| HSA-MIR-6743-5P | 99.48 | 63.60 | 721 |
| HSA-MIR-6507-5P | 99.36 | 70.46 | 2524 |
| HSA-MIR-4505 | 99.27 | 67.81 | 2678 |
| HSA-MIR-10522-5P | 99.26 | 68.50 | 2087 |
| HSA-MIR-5787 | 99.22 | 67.86 | 2628 |
| HSA-MIR-491-5P | 99.13 | 65.98 | 1468 |
| HSA-MIR-6809-5P | 99.13 | 68.45 | 1223 |
| HSA-MIR-3688-5P | 99.12 | 69.67 | 1091 |
| HSA-MIR-4764-5P | 98.88 | 65.53 | 894 |
Functional genomics
gnomAD constraint: pLI 2.89e-06, LOEUF 0.609, missense Z 2.27 — population loss-of-function intolerance (pLI ≥ 0.9 = LoF-intolerant; lower LOEUF = more constrained). gnomAD
Regional missense constraint (gnomAD)
ENST00000042381 splits into 3 regions with different missense tolerance; 0 are missense-constrained. Missense variants in a constrained region (low observed/expected) are more likely to be pathogenic. gnomAD
| Region (GRCh38) | Missense obs / exp | o/e | Constrained |
|---|---|---|---|
| 16:67,538,447–67,539,052 | 165 / 145.5 | 1.13 | no |
| 16:67,539,053–67,541,691 | 202 / 295.9 | 0.68 | no |
| 16:67,541,692–67,546,460 | 1005 / 1144.7 | 0.88 | no |
Literature-anchored findings (GeneRIF, showing 1)
- These results reveal a previously unidentified pathway downstream of RHO that regulates the polarity of migrating cells through Golgi reorientation in a FAM65A-, CCM3- and MST3- and MST4-dependent manner. (PMID:27807006)
Cross-species orthologs
4 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | ripor1 | ENSDARG00000062178 |
| mus_musculus | Ripor1 | ENSMUSG00000038604 |
| rattus_norvegicus | Ripor1 | ENSRNOG00000017604 |
| caenorhabditis_elegans | WBGENE00045063 |
Paralogs (2): RIPOR3 (ENSG00000042062), RIPOR2 (ENSG00000111913)
Mouse-model phenotypes
Observed phenotypes of the mouse ortholog (MGI:1922937) from MGI (Alliance of Genome Resources) — knockout/mutant phenotypes, ranked by annotation count. 1 distinct phenotype terms.
| Mouse phenotype (MP) | Records |
|---|---|
| preweaning lethality, complete penetrance | 1 |
Additional cross-species homologs
Sequence homologs in species beyond Ensembl Compara’s model organisms, by Diamond local protein alignment (% sequence identity; best hit per species). Lower-identity rows are more distant homologs. The matched accessions’ gene symbols aren’t in biobtree yet, so each row shows the UniProt accession.
| Organism | UniProt | Identity | Method |
|---|---|---|---|
| Gallus gallus | Q5F3L9 | 83.4% | Diamond |
| Coturnix japonica | A9ZLX4 | 83.1% | Diamond |
| Bos taurus | Q3B7M3 | 82.7% | Diamond |
Genomic neighbors (locus context)
Genes flanking this one on the chromosome (NCBI/Entrez gene neighborhood). Positional context only — some neighbors share regulatory elements (bidirectional promoters, antisense/overlapping transcripts), but chromosomal adjacency is not itself a functional relationship (see Interactions for that).
| Symbol | Type | Entrez |
|---|---|---|
| ATP6V0D1-DT | ncRNA | 101927837 |
| CTCF | protein-coding | 10664 |
| CTCF-DT | ncRNA | 107984813 |
| AGRP | protein-coding | 181 |
| ATP6V0D1 | protein-coding | 9114 |
| HSD11B2 | protein-coding | 3291 |
| CARMIL2 | protein-coding | 146206 |
| PARD6A | protein-coding | 50855 |
| ACD | protein-coding | 65057 |
| ZDHHC1 | protein-coding | 29800 |
Protein
Protein identifiers
Rho family-interacting cell polarization regulator 1 — Q6ZS17 (reviewed: Q6ZS17)
All UniProt accessions (12): A0A0A0MTL6, A0A0G2JLA4, Q6ZS17, H3BMG9, H3BP86, H3BQI5, H3BS40, H3BSV5, H3BSX9, H3BU12, H3BUP6, H3BV02
UniProt curated annotations — full annotation on UniProt →
Function. Downstream effector protein for Rho-type small GTPases that plays a role in cell polarity and directional migration. Acts as an adapter protein, linking active Rho proteins to STK24 and STK26 kinases, and hence positively regulates Golgi reorientation in polarized cell migration upon Rho activation. Involved in the subcellular relocation of STK26 from the Golgi to cytoplasm punctae in a Rho- and PDCD10-dependent manner upon serum stimulation.
Subunit / interactions. Interacts (via N-terminus) with RHOA (GTP-bound form); this interaction links active RHOA to STK24 and STK26 kinases. Interacts with RHOB. Interacts with RHOC. Interacts (via C-terminus) with PDCD10; this interaction occurs in a Rho-independent manner. Interacts (via C-terminus) with STK24; this interaction occurs in a PDCD10-dependent and Rho-independent manner. Interacts (via C-terminus) with STK26; this interaction occurs in a PDCD10-dependent and Rho-independent manner. Interacts (via N-terminus) with 14-3-3 proteins; these interactions occur in a Rho-dependent manner.
Subcellular location. Cytoplasm. Golgi apparatus.
Similarity. Belongs to the RIPOR family.
Isoforms (4)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q6ZS17-1 | 1 | yes |
| Q6ZS17-2 | 2 | |
| Q6ZS17-3 | 3 | |
| Q6ZS17-4 | 4 |
RefSeq proteins (5): NP_001180451, NP_001180452, NP_001180453, NP_001397814, NP_078795* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR011989 | ARM-like | Homologous_superfamily |
| IPR016024 | ARM-type_fold | Homologous_superfamily |
| IPR026136 | RIPOR3 | Family |
| IPR031780 | RIPOR1-3_N | Domain |
Pfam: PF15903
UniProt features (29 total): compositionally biased region 8, modified residue 8, sequence conflict 5, region of interest 3, splice variant 3, chain 1, coiled-coil region 1
Structure
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q6ZS17-F1 | 63.47 | 0.33 |
Human Protein Atlas
Protein class: Predicted intracellular proteins
Protein evidence: Evidence at protein level
Subcellular location (HPA, imaging): golgi apparatus; cytosol
Antibody reliability (HPA): IH uncertain · IF supported
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Post-translational modifications (8)
| Type | Positions |
|---|---|
| Phosphoserine | 22, 349, 351, 456, 459, 874, 875 |
| Phosphothreonine | 355 |
Function
Pathways and Gene Ontology
Reactome pathways
0 curated (TAS) of 0; 0 disease pathways. Curated-first; evidence = TAS (manually curated) vs IEA (electronic inference).
MSigDB gene sets: 231 (showing top):
ATF_B, WANG_CLIM2_TARGETS_UP, chr16q22, GOBP_INTRACELLULAR_PROTEIN_TRANSPORT, GOBP_RESPONSE_TO_PEPTIDE, RORA1_01, GOBP_POSITIVE_REGULATION_OF_INTRACELLULAR_PROTEIN_TRANSPORT, GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_UP, GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_UP, GOBP_POSITIVE_REGULATION_OF_PROTEIN_LOCALIZATION, GOBP_REGULATION_OF_GTPASE_ACTIVITY, GOBP_REGULATION_OF_SMALL_GTPASE_MEDIATED_SIGNAL_TRANSDUCTION, AP4_Q6, MEF2_02, GGGTGGRR_PAX4_03
GO Biological Process (10): Rho protein signal transduction (GO:0007266), cellular response to starvation (GO:0009267), response to wounding (GO:0009611), positive regulation of cell migration (GO:0030335), protein localization to Golgi apparatus (GO:0034067), negative regulation of Rho protein signal transduction (GO:0035024), establishment of Golgi localization (GO:0051683), positive regulation of intracellular protein transport (GO:0090316), cellular response to chemokine (GO:1990869), negative regulation of Rho guanyl-nucleotide exchange factor activity (GO:2001107)
GO Molecular Function (2): 14-3-3 protein binding (GO:0071889), protein binding (GO:0005515)
GO Cellular Component (7): cytoplasm (GO:0005737), Golgi apparatus (GO:0005794), cytosol (GO:0005829), vesicle membrane (GO:0012506), membrane (GO:0016020), cell leading edge (GO:0031252), extracellular exosome (GO:0070062)
GO top-level categories
32 GO namespaces:
| Category | Terms |
|---|---|
| cellular anatomical structure | 4 |
| cytoplasm | 2 |
| small GTPase-mediated signal transduction | 1 |
| cellular response to nutrient levels | 1 |
| cellular response to stress | 1 |
| response to starvation | 1 |
| response to stress | 1 |
| cell migration | 1 |
| regulation of cell migration | 1 |
| positive regulation of cell motility | 1 |
| protein localization to organelle | 1 |
| Rho protein signal transduction | 1 |
| regulation of Rho protein signal transduction | 1 |
| negative regulation of small GTPase mediated signal transduction | 1 |
| Golgi localization | 1 |
| establishment of localization in cell | 1 |
| establishment of organelle localization | 1 |
| intracellular protein transport | 1 |
| positive regulation of intracellular transport | 1 |
| regulation of intracellular protein transport | 1 |
| positive regulation of protein transport | 1 |
| cellular response to cytokine stimulus | 1 |
| response to chemokine | 1 |
| negative regulation of guanyl-nucleotide exchange factor activity | 1 |
| protein binding | 1 |
| binding | 1 |
| intracellular anatomical structure | 1 |
| endomembrane system | 1 |
| intracellular membrane-bounded organelle | 1 |
| organelle membrane | 1 |
| vesicle | 1 |
| extracellular vesicle | 1 |
Experimentally-supported GO annotations
GO terms backed by direct experimental evidence (ECO experimental codes) — 17 of 19 annotations. The rest are phylogenetic / computational / electronic (IEA).
17 experimentally-supported GO terms:
| GO term | NS | Evidence |
|---|---|---|
| Rho protein signal transduction | BP | mutant phenotype |
| cellular response to chemokine | BP | mutant phenotype |
| cellular response to starvation | BP | mutant phenotype |
| establishment of Golgi localization | BP | mutant phenotype |
| negative regulation of Rho guanyl-nucleotide exchange factor activity | BP | mutant phenotype |
| negative regulation of Rho protein signal transduction | BP | mutant phenotype |
| positive regulation of cell migration | BP | mutant phenotype |
| positive regulation of intracellular protein transport | BP | mutant phenotype |
| protein localization to Golgi apparatus | BP | mutant phenotype |
| response to wounding | BP | mutant phenotype |
| Golgi apparatus | CC | direct assay |
| cell leading edge | CC | direct assay |
| cytoplasm | CC | direct assay |
| cytosol | CC | direct assay |
| extracellular exosome | CC | high-throughput assay |
| membrane | CC | direct assay |
| 14-3-3 protein binding | MF | direct assay |
Protein interactions and networks
STRING
showing 15 of 732 interactions by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| RIPOR1 | PSKH1 | P11801 | 553 |
| RIPOR1 | STK26 | Q9P289 | 460 |
| RIPOR1 | RNF17 | Q9BXT8 | 438 |
| RIPOR1 | R3HDM2 | Q9Y2K5 | 431 |
| RIPOR1 | PARP4 | Q9UKK3 | 417 |
| RIPOR1 | ZMYM5 | Q9UJ78 | 416 |
| RIPOR1 | PDCD10 | Q9BUL8 | 400 |
| RIPOR1 | PLA2G15 | Q8NCC3 | 397 |
| RIPOR1 | EDC4 | Q6P2E9 | 395 |
| RIPOR1 | PPP4R3B | Q5MIZ7 | 386 |
| RIPOR1 | NPEPL1 | Q8NDH3 | 383 |
| RIPOR1 | HIPK1 | Q86Z02 | 379 |
| RIPOR1 | TTC7A | Q9ULT0 | 375 |
| RIPOR1 | NUCKS1 | Q9H1E3 | 374 |
| RIPOR1 | STRIP1 | Q5VSL9 | 354 |
IntAct
Human interaction partners of RIPOR1 in IntAct, one row per partner (best MIscore; records = supporting IntAct interaction records).
4 partners by confidence:
| Partner | Interaction type | MIscore | Records |
|---|---|---|---|
| MAP1LC3B | physical association | 0.370 | 1 |
| STK25 | association | 0.350 | 1 |
| FMR1 | physical association | 0.000 | 1 |
| MYO7A | physical association | 0.000 | 1 |
Disease & clinical
Genetic variants
Variant evidence for RIPOR1: 201 ClinVar records (0 pathogenic / likely pathogenic); 4 GWAS associations.
ClinVar
201 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 166 |
| Likely benign | 10 |
| Benign | 0 |
SpliceAI
Top 10 splice-impact sites by Δscore (adjacent positions with the same effect merged into one range; 25 predictions of 1,761):
| Position(s) | Effect | Δscore | Sites |
|---|---|---|---|
| 16:67538551–67538552 | donor_loss | 1.0000 | 3 |
| 16:67539719 | acceptor_gain | 1.0000 | |
| 16:67539848 | acceptor_gain | 1.0000 | |
| 16:67539900–67539901 | donor_loss | 1.0000 | 3 |
| 16:67540044 | acceptor_gain | 1.0000 | |
| 16:67540206–67540207 | donor_loss | 1.0000 | 5 |
| 16:67540364–67540365 | donor_loss | 1.0000 | 4 |
| 16:67541428–67541429 | acceptor_loss | 1.0000 | 5 |
| 16:67541556 | donor_gain | 1.0000 | |
| 16:67541565 | donor_gain | 1.0000 |
AlphaMissense
2,635 missense substitutions predicted likely pathogenic (of 7,843 scored), across 645 residues. Top 20 hotspot residues, ranked by the number of likely-pathogenic substitutions (of those reachable by a single-nucleotide change), then by mean score:
| Residue | Likely-pathogenic substitutions | Mean am_pathogenicity | Max am_pathogenicity |
|---|---|---|---|
| M163 | 9 | 0.878 | 0.986 |
| M213 | 9 | 0.878 | 0.994 |
| D226 | 8 | 0.988 | 0.998 |
| D305 | 8 | 0.982 | 0.994 |
| F854 | 8 | 0.975 | 0.998 |
| D123 | 8 | 0.970 | 0.996 |
| F1223 | 8 | 0.970 | 0.997 |
| F219 | 8 | 0.965 | 1.000 |
| D1176 | 8 | 0.963 | 0.994 |
| F295 | 8 | 0.960 | 0.995 |
| F856 | 8 | 0.955 | 0.997 |
| F209 | 8 | 0.954 | 0.999 |
| F23 | 8 | 0.953 | 0.996 |
| F118 | 8 | 0.951 | 0.998 |
| F138 | 8 | 0.949 | 0.999 |
| D121 | 8 | 0.946 | 0.990 |
| F1213 | 8 | 0.923 | 0.985 |
| F260 | 8 | 0.918 | 0.993 |
| F323 | 8 | 0.918 | 0.982 |
| F363 | 8 | 0.914 | 0.991 |
HPA cancer prognostics
RNA cancer specificity: Low cancer specificity
Human Protein Atlas survival analysis — favorable = higher expression predicts better survival.
3 prognostic cancer types:
| Cancer | Prognostic | p-value |
|---|---|---|
| Kidney Renal Clear Cell Carcinoma (TCGA) | favorable | 1.12e-07 |
| Lung Squamous Cell Carcinoma (TCGA) | unfavorable | 5.18e-05 |
| Pancreatic Adenocarcinoma (validation) | unfavorable | 0.000412 |
Disease associations
OMIM: gene MIM:619842 | disease phenotypes:
GWAS associations
4 associations:
| Study | Trait | p-value |
|---|---|---|
| GCST006979_878 | Heel bone mineral density | 5e-15 |
| GCST010002_165 | Refractive error | 2e-14 |
| GCST90002388_355 | Lymphocyte count | 7e-11 |
| GCST010083_159 | Hemoglobin levels | 1e-10 |
EFO canonical traits (from GWAS)
3 canonical traits:
| EFO ID | Trait name |
|---|---|
| EFO:0009270 | heel bone mineral density |
| EFO:0004509 | hemoglobin measurement |
| EFO:0004587 | lymphocyte count |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (CPIC guideline: no)
CTD chemical–gene interactions
30 total (human), top 30 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Arsenic | affects methylation, increases abundance, increases expression | 2 |
| aristolochic acid I | increases expression | 1 |
| FR900359 | increases phosphorylation | 1 |
| dicrotophos | increases expression | 1 |
| triphenyl phosphate | affects expression | 1 |
| bisphenol A | decreases methylation | 1 |
| lead acetate | increases expression | 1 |
| sodium arsenate | increases abundance, increases expression | 1 |
| ethyl-p-hydroxybenzoate | increases expression | 1 |
| beta-lapachone | increases expression | 1 |
| beta-methylcholine | affects expression | 1 |
| ICG 001 | increases expression | 1 |
| Decitabine | affects expression | 1 |
| Sunitinib | increases expression | 1 |
| Leflunomide | increases expression | 1 |
| Acetaminophen | increases expression | 1 |
| Cadmium | decreases expression, increases abundance | 1 |
| Caffeine | affects phosphorylation | 1 |
| Calcitriol | decreases expression | 1 |
| Cisplatin | affects expression | 1 |
| Doxorubicin | decreases expression | 1 |
| Rotenone | decreases expression | 1 |
| Silicon Dioxide | increases expression | 1 |
| Tetrachlorodibenzodioxin | increases expression | 1 |
| Valproic Acid | affects expression | 1 |
| Vanadates | increases expression | 1 |
| Cyclosporine | increases expression | 1 |
| Aflatoxin B1 | increases methylation | 1 |
| Sodium Selenite | increases expression | 1 |
| Cadmium Chloride | decreases expression, increases abundance | 1 |
Cellosaurus cell lines
1 cell lines: 1 cancer cell line
First 10 cell lines (id-ordered, not curated):
| Cellosaurus | Name | Category | Sex |
|---|---|---|---|
| CVCL_B2DV | Abcam HeLa RIPOR1 KO | Cancer cell line | Female |
Clinical trials (associated diseases)
Via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.